State-of-the-art enzyme development company, Entropix, secures investment from LYVA Labs

Entropix, a company creating high-performance enzymes for use across a range of sectors, has secured a six-figure investment from LYVA Labs.

LYVA Labs was established with £11m from Liverpool City Region’s Combined Authority, to drive innovation and economic growth by turning great ideas into high-growth businesses and creating partnerships to attract investment.

Entropix Ltd has secured investment from LYVA Labs’ Health and Life Sciences Fund, for start-ups based in Liverpool City Region. Entropix is an enzyme development company specialising in creating novel, high-performance enzymes and biocatalysts for use in diagnostics, pharmaceuticals, food and drink, and plastic recycling, using state-of-the-art molecular biology and machine learning computational methods.

Read more…

Group pic LYVA Entropix